An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)
Recruiting
- Conditions
- Hypertension
- Registration Number
- NCT06214832
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Brief Summary
This study identify prescription patterns of Lodient Tab and evaluate the changes of the hypertension symptoms (BP pressure) who are first prescribed and taking Lodient Tab.
- Detailed Description
This study aims to observe changes in symptoms according to the treatment effect of hypertension for 6 months after Lodient Tab prescription.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 4000
Inclusion Criteria
- Adults over 19 years of age
- A person diagnosed with hypertension
- A person who has been first prescribed Lodient Tab within the past 4 months as of the IRB approval date or is scheduled to be prescribed Lodient Tab
- A person who voluntarily agreed in writing to this study
Exclusion Criteria
- Pregnant women or nursing mothers
- Persons subject to prohibition according to the permission of the Lodient Tab
- Patients who in the judgement of the investigator, were inappropriate to participate in the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of patients who met target systolic blood pressure (less than 140mmHg) at 6 months of prescription for Lodient Tab compared to baseline at 6 months of prescription for Lodient Tab compared to baseline The percentage of patients who met target systolic blood pressure (less than 140mmHg) at 6 months of prescription for Lodient Tab compared to baseline
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Seoul song clinic
🇰🇷Seoul, Korea, Republic of